FDA Approved: REPAGLINIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX, LLC's original Abbreviated New Drug Application for repaglinide, a meglitinide used to improve glycemic control in adults with ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

ORIG AP for REPAGLINIDE (REPAGLINIDE)